arrow_back Civic Audit
Share share

Mandatory Newborn Screening for Congenital Cytomegalovirus (CMV) Infection

This Act allows for the screening of newborns up to 21 days old for congenital Cytomegalovirus (CMV) in hospitals. The goal is early detection of this condition, which can cause serious health issues in children. Furthermore, the law allocates funds for research, diagnostic development, and public education regarding CMV, enhancing the health security of the youngest citizens.
Key points
Introduction of congenital Cytomegalovirus (CMV) screening for infants up to 21 days old in healthcare facilities.
Provision of grants to states to develop screening standards, data collection, and education for healthcare providers and the public about CMV.
Increased funding for research by the National Institutes of Health (NIH) into new screening techniques, diagnostics, prevention, and treatment of congenital CMV.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_5435
Sponsor: Rep. Lawler, Michael [R-NY-17]
Process start date: 2025-09-17
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stop CMV Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5435.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-17.

What are the main provisions?

Key points include:

  • Introduction of congenital Cytomegalovirus (CMV) screening for infants up to 21 days old in healthcare facilities.
  • Provision of grants to states to develop screening standards, data collection, and education for healthcare providers and the public about CMV.
  • Increased funding for research by the National Institutes of Health (NIH) into new screening techniques, diagnostics, prevention, and treatment of congenital CMV.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Lawler, Michael [R-NY-17].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Family